Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Xeris Pharmaceuticals Inc
(NQ:
XERS
)
1.760
-0.120 (-6.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Xeris Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
Xeris Biopharma Holdings: Q1 Earnings Insights
May 11, 2022
Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
Xeris Pharmaceuticals's Earnings Outlook
May 10, 2022
Xeris Pharmaceuticals (NASDAQ:XERS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
XERS Stock Pops on Huge FDA News. Here’s What to Know.
December 31, 2021
The FDA approved Xeris' Recorlev drug for certain adult patients with Cushing's syndrome, sending XERS stock higher.
Via
InvestorPlace
Analyst Ratings For Xeris Biopharma Holdings
March 16, 2022
Xeris Biopharma Holdings (NASDAQ:XERS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
Via
Benzinga
Recap: Xeris Biopharma Holdings Q4 Earnings
March 10, 2022
Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM. Here's what investors need to know about the...
Via
Benzinga
A Preview Of Xeris Pharmaceuticals's Earnings
March 09, 2022
Xeris Pharmaceuticals (NASDAQ:XERS) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement....
Via
Benzinga
18 Stocks Moving in Monday's Pre-Market Session
January 31, 2022
Gainers FGI Industries Ltd. (NASDAQ: FGI) rose 92.8% to $7.27 in pre-market trading after jumping 19% on Friday. The company, last week, priced its IPO at $6 per...
Via
Benzinga
Xeris Biopharma Eyes High End Of FY21 Sales Outlook
January 18, 2022
Xeris Biopharma Holdings Inc (NASDAQ: XERS) has reaffirmed its preliminary 2021 pro forma sales at a high-end of $76 million - $80 million guidance, approximately...
Via
Benzinga
PANTHERx Rare Selected By Xeris Pharmaceuticals To Distribute Recorlev
January 13, 2022
PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy...
Via
Benzinga
40 Biggest Movers From Friday
January 03, 2022
Gainers Nutriband Inc. (NASDAQ: NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Property Office has fully issued its...
Via
Benzinga
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. Here are the key catalysts that can sway biotech stocks in the unfolding week.
Via
Talk Markets
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were...
Via
Benzinga
Mid-Afternoon Market Update: Dow Rises 50 Points; Nutriband Shares Spike Higher
December 31, 2021
Toward the end of trading Friday, the Dow traded up 0.14% to 36,449.17 while the NASDAQ fell 0.20% to 15,710.56. The S&P also rose, gaining 0.08% to 4,782.32. The U.S. has the...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Xeris Biopharma Holdings
December 31, 2021
Analysts have provided the following ratings for Xeris Biopharma Holdings (NASDAQ:
Via
Benzinga
Mid-Day Market Update: Crude Oil Down 1%; Xeris Biopharma Shares Jump
December 31, 2021
Midway through trading Friday, the Dow traded down 0.08% to 36,370.19 while the NASDAQ fell 0.07% to 15,730.21. The S&P also fell, dropping 0.02% to 4,777.65. The U.S. has the...
Via
Benzinga
21 Stocks Moving In Friday's Mid-Day Session
December 31, 2021
Gainers Nutriband Inc. (NASDAQ: NTRB) shares jumped 120.2% to $8.61 after the company announced the Korean Intellectual Property Office has fully issued its patent titled "...
Via
Benzinga
4 Biggest Price Target Changes For Friday
December 31, 2021
SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading....
Via
Benzinga
Why Xeris Biopharma Shares Are Rising Today
December 31, 2021
Xeris Biopharma Holdings Inc (NASDAQ: XERS) is trading higher Friday morning after the company announced U.S. Food and Drug Administration approval of Recorlev for the...
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
December 31, 2021
Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a stock repurchase program of 500,000 shares. Xeris...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower On Final Trading Day Of 2021
December 31, 2021
Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade on the final trading day of 2021. The Dow Jones dropped around 90 points, snapping a six-session...
Via
Benzinga
5 Stocks To Watch For December 31, 2021
December 31, 2021
Some of the stocks that may grab investor focus today are: Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist...
Via
Benzinga
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
December 27, 2021
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout...
Via
Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:
Via
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...
Via
Benzinga
70 Biggest Movers From Yesterday
November 16, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...
Via
Benzinga
4 Penny Stocks Insiders Are Buying
November 15, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.